Article

bradenton.com on 2019-02-01 13:05

Merck 4Q powered by cancer treatment sales

Merck posts better than expected profit for the fourth quarter with revenue up 4.6 percent.

SETH WENIG

Related news

Merck 4Q powered by cancer treatment sales reviewtimes.com
New Jersey , Kenilworth
Merck reports surging sales of vaccines and key cancer drug bradenton.com
New Jersey , China , Wall Street , Kenilworth
Sales of Merck’s cancer treatment Keytruda soar in 3Q thenewstribune.com
Wall Street , Kenilworth
Merck beats 4Q profit forecast, misses Street view on sales wkrg.com
Wall Street , Kenilworth
Merck beats 4Q profit forecast, misses on sales The Salt Lake Tribune
Europe , New Jersey , Wall Street , West Point
Merck tops 4Q profit forecasts dothaneagle.com
Wall Street , New Jersey , Kenilworth
Merck posts global sales of $11B in third quarter bradenton.com
New Jersey , Kenilworth
FMerck wins approval for skin cancer treatment ft.com
Merck scores a hit with Keytruda, watches spending in 4Q thenewstribune.com
New Jersey , Wall Street , Kenilworth
Merck sales soar but 3Q profit dips on higher spending The Wichita Eagle
New Jersey , Wall Street , Kenilworth